Claudio Ramírez

713 total citations
17 papers, 563 citations indexed

About

Claudio Ramírez is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claudio Ramírez has authored 17 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Ophthalmology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claudio Ramírez's work include Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (6 papers) and Retinal and Macular Surgery (3 papers). Claudio Ramírez is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Retinal Development and Disorders (6 papers) and Retinal and Macular Surgery (3 papers). Claudio Ramírez collaborates with scholars based in United States, Egypt and United Kingdom. Claudio Ramírez's co-authors include M. Cristina Kenney, Baruch D. Kuppermann, Deepika Malik, David S. Boyer, Javier Cáceres‐del‐Carpio, Marilyn Chwa, Shari R. Atilano, Payam Falatoonzadeh, Nitin Udar and S. Michal Jazwinski and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and American Heart Journal.

In The Last Decade

Claudio Ramírez

16 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Ramírez United States 11 277 190 96 64 51 17 563
Akira Obana Japan 20 240 0.9× 652 3.4× 348 3.6× 58 0.9× 64 1.3× 92 1.3k
F. Legros Belgium 17 169 0.6× 20 0.1× 36 0.4× 37 0.6× 81 1.6× 47 833
Rohit Shetty India 17 81 0.3× 298 1.6× 305 3.2× 17 0.3× 85 1.7× 55 857
Neha Khandelwal India 22 165 0.6× 780 4.1× 573 6.0× 10 0.2× 45 0.9× 41 1.1k
Xiujun Fu United States 11 154 0.6× 25 0.1× 31 0.3× 11 0.2× 69 1.4× 16 545
Xiuping Zhu China 11 127 0.5× 66 0.3× 162 1.7× 3 0.0× 45 0.9× 25 541
Shiu‐Jau Chen Taiwan 13 81 0.3× 23 0.1× 21 0.2× 7 0.1× 78 1.5× 45 375
Jinyu Zhang China 12 67 0.2× 39 0.2× 36 0.4× 3 0.0× 31 0.6× 25 341
Sophia Seen Singapore 8 53 0.2× 178 0.9× 150 1.6× 41 0.6× 40 0.8× 9 460
Acácio Alves de Souza Lima Filho Brazil 18 152 0.5× 553 2.9× 528 5.5× 6 0.1× 21 0.4× 55 907

Countries citing papers authored by Claudio Ramírez

Since Specialization
Citations

This map shows the geographic impact of Claudio Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Ramírez more than expected).

Fields of papers citing papers by Claudio Ramírez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Ramírez. The network helps show where Claudio Ramírez may publish in the future.

Co-authorship network of co-authors of Claudio Ramírez

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Ramírez. A scholar is included among the top collaborators of Claudio Ramírez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Ramírez. Claudio Ramírez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Montero, David A., et al.. (2019). Antimicrobial properties of a novel copper-based composite coating with potential for use in healthcare facilities. Antimicrobial Resistance and Infection Control. 8(1). 3–3. 90 indexed citations
2.
Ramírez, Claudio, Kevin Schneider, Shari R. Atilano, et al.. (2017). Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Müller Cells. Journal of Ocular Pharmacology and Therapeutics. 33(8). 610–619. 14 indexed citations
3.
Ramírez, Claudio, Javier Cáceres‐del‐Carpio, Justin Chu, et al.. (2015). Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells. Journal of Ocular Pharmacology and Therapeutics. 32(2). 102–108. 22 indexed citations
4.
Cáceres‐del‐Carpio, Javier, Claudio Ramírez, Deepika Malik, et al.. (2014). Effects of Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept on Cultured Human Retinal Müller Cells. Investigative Ophthalmology & Visual Science. 55(13). 598–598. 1 indexed citations
5.
Malik, Deepika, Payam Falatoonzadeh, Javier Cáceres‐del‐Carpio, et al.. (2014). Human Retinal Transmitochondrial Cybrids with J or H mtDNA Haplogroups Respond Differently to Ultraviolet Radiation: Implications for Retinal Diseases. PLoS ONE. 9(6). e99003–e99003. 28 indexed citations
6.
Malik, Deepika, Javier Cáceres‐del‐Carpio, Claudio Ramírez, et al.. (2014). Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. British Journal of Ophthalmology. 98(Suppl 1). i11–i16. 103 indexed citations
7.
Kenney, M. Cristina, Marilyn Chwa, Shari R. Atilano, et al.. (2013). Mitochondrial DNA Variants Mediate Energy Production and Expression Levels for CFH, C3 and EFEMP1 Genes: Implications for Age-Related Macular Degeneration. PLoS ONE. 8(1). e54339–e54339. 84 indexed citations
8.
Ramírez, Claudio, Khoa Pham, Marilyn Chwa, et al.. (2013). Hydroquinone induces oxidative and mitochondrial damage to human retinal Müller cells (MIO-M1). NeuroToxicology. 39. 102–108. 14 indexed citations
9.
Kenney, M. Cristina, Marilyn Chwa, Shari R. Atilano, et al.. (2013). Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: Implications for population susceptibility to diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(2). 208–219. 128 indexed citations
10.
Ramírez, Claudio, et al.. (2012). Hydroquinone Induces Autophagy in Human Retinal Pigment Epithelial Cells in vitro. Investigative Ophthalmology & Visual Science. 53(14). 4276–4276. 1 indexed citations
11.
Zacharias, Leandro Cabral, Claudio Ramírez, M. Cristina Kenney, et al.. (2011). The Effects of Commercially Available Preservative-Free FDA-Approved Triamcinolone (Triesence ® ) on Retinal Cells in Culture. Journal of Ocular Pharmacology and Therapeutics. 27(2). 143–150. 9 indexed citations
12.
Zacharias, Leandro Cabral, et al.. (2011). The effects of commercially available preservative-free FDA-approved triamcinolone (Triesence®) on retinal cells in culture.. Investigative Ophthalmology & Visual Science. 27(2). 143–50. 1 indexed citations
13.
Mansoor, Saffar, et al.. (2010). Inhibition of Apoptosis in Human Retinal Pigment Epithelial Cells Treated with Benzo(e)Pyrene, a Toxic Component of Cigarette Smoke. Investigative Ophthalmology & Visual Science. 51(5). 2601–2601. 28 indexed citations
14.
Aranda, Mario, et al.. (2007). Transfección de la línea celular de salmón CHSE-214 usando un liposoma no comercial. Archivos de medicina veterinaria. 39(2). 1 indexed citations
15.
Ramírez, Claudio, et al.. (1989). Intravenous ciprofloxacin or ceftazidime in selected infections. The American Journal of Medicine. 87(5). S191–S194. 8 indexed citations
16.
Ramírez, Claudio, et al.. (1984). Group A beta-hemolytic streptococcus endocarditis. American Heart Journal. 108(5). 1383–1386. 19 indexed citations
17.
Panwalker, Anand P., et al.. (1981). Clinical Efficacy of Moxalactam with Emphasis on Infections Due to Multidrug-Resistant Organisms in Patients with Renal Insufficiency. Chemotherapy. 27(4). 287–295. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026